UMR 1253, iBrain, Université de Tours, INSERM, Tours, France.
UMR 1253, iBrain, Université de Tours, INSERM, Tours, France; GICC EA 7501, Université de Tours, Tours, France.
Ultrasound Med Biol. 2022 Nov;48(11):2174-2198. doi: 10.1016/j.ultrasmedbio.2022.06.021. Epub 2022 Aug 30.
Recent technological developments in ultrasound (US) imaging and ultrasound contrast agents (UCAs) have improved diagnostic confidence in echography. In the clinical management of melanoma, contrast-enhanced ultrasound (CEUS) imaging complements conventional US imaging (i.e., high-resolution US and Doppler imaging) for clinical examination and therapeutic follow-up. These developments have set into motion the combined use of ultrasound and UCAs as a new modality for drug delivery. This modality, called sonoporation, has emerged as a non-invasive, targeted and safe method for the delivery of therapeutic drugs into melanoma. This review focuses on the results and prospects of using US and UCAs as dual modalities for CEUS imaging and melanoma treatment.
近年来,超声(US)成像和超声造影剂(UCAs)技术的发展提高了超声检查的诊断信心。在黑色素瘤的临床管理中,对比增强超声(CEUS)成像补充了传统的超声成像(即高分辨率超声和多普勒成像)用于临床检查和治疗随访。这些发展促使将超声和 UCAs 联合用于药物输送的新方法。这种方法称为声孔作用,已成为将治疗药物递送至黑色素瘤的一种非侵入性、靶向和安全的方法。本综述重点介绍了 US 和 UCAs 作为 CEUS 成像和黑色素瘤治疗的双重模式的结果和前景。